Screening for melanoma in aging patients
Wolf, J.; Harris, R.; Ferris, L.K.
Cutis 91(2): 81-86
2013
ISSN/ISBN: 0011-4162 PMID: 23513556 Document Number: 664296
Despite recent advances, there is still no highly effective treatment of metastatic melanoma. By contrast, melanoma in situ essentially is a surgically curable disease. Therefore, the most promising approach to reducing melanoma mortality rates is the prompt detection and treatment of early-stage melanoma. The incidence of melanoma in the United States is increasing over time and the incidence increases with age. Thus early detection of melanoma via patient and physician screening in the aging population has the potential to substantially reduce melanoma mortality.
Document emailed within 1 workday
Related Documents
Waldmann, A.; Nolte, S.; Weinstock, M.A.; Breitbart, E.W.; Eisemann, N.; Geller, A.C.; Greinert, R.; Volkmer, B.; Katalinic, A. 2012: Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening British Journal of Cancer 106(5): 970-974Witte, M.E.; Gerrits, E.G.; Klaase, J.M.; Mastboom, W.J.B.; Sterk, L.M.T. 2006: Distinguishing nodal naevus from melanoma metastases in the sentinel node in patients with melanoma Nederlands Tijdschrift Voor Geneeskunde 150(19): 1072-1076
Akimaru, K.; Shoji, T.; Seigler, H.F. 1984: In vivo evaluation of cellular immunity in melanoma patients against melanoma Nihon Geka Gakkai Zasshi 85(2): 93-101
Sawada, T.; Shikata, T.; Matsumura, T.; Kawakatsu, H.; Sugimoto, T. 1994: Analysis of 598 cases of neuroblastoma (NB) detected by screening and changes in the age distribution and incidence of NB patients after mass screening in infants in Japan. NB Screening Study Group Progress in Clinical and Biological Research 385: 371-375
Bégány, A.; Vezekényi, K. 1990: Melanoma screening in Debrecen Orvosi Hetilap 131(41): 2259-2261
Bernengo, M.G.; Doveil, G.C.; Lisa, F.; Pippione, M.; Aloi, F.G.; Stuardi, C.; Zina, G. 1986: Cutaneous melanoma at the Turin Melanoma Center. I. Survival and correlation with clinical and histologic prognostic factors in 502 patients in stage I (1975-1985) Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 121(5): 311-326
Buraggi, G.L.; Callegaro, L.; Mariani, G.; Turrin, A.; Cascinelli, N.; Attili, A.; Bombardieri, E.; Terno, G.; Plassio, G.; Dovis, M. 1985: Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments Cancer Research 45(7): 3378-3387
Lin, Y-Yin.; Huang, C-Shan. 2016: Aging in Taiwan: Building a Society for Active Aging and Aging in Place Gerontologist 56(2): 176-183
Friedman, K.P.; Whitaker-Worth, D.L.; Grin, C.; Grant-Kels, J.M. 2004: Melanoma screening behavior among primary care physicians Cutis 74(5): 305-311
de Rooij, M.J.; Rampen, F.H.; Schouten, L.J.; Neumann, H.A. 1997: Factors influencing participation among melanoma screening attenders Acta Dermato-Venereologica 77(6): 467-470
Bernengo, M.G.; Doveil, G.C.; Lisa, F.; Stuardi, C.; Zina, G. 1987: Cutaneous melanoma at the Turin Melanoma Center. II. Risk of metastasis and free interval in relation to the clinical and histological prognostic factors in 502 patients in stage I (1975-1985) Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 122(4): 143-153
Friedel, W.; Boden, U.; Boden, C.; Rürup, B.; Schulz, J.; Schulz, H.J.; Rühland, W. 1970: Significance of serum alkaline phosphatase as a screening parameter in the health care of aging and aged Das Deutsche Gesundheitswesen 25(41): 1954-1957
Shannan, B.; Seifert, M.; Leskov, K.; Boothman, D.; Pföhler, C.; Tilgen, W.; Reichrath, J. 2006: Clusterin (CLU) and melanoma growth: CLU is expressed in malignant melanoma and 1,25-dihydroxyvitamin D3 modulates expression of CLU in melanoma cell lines in vitro Anticancer Research 26(4a): 2707-2716
Stoychkov, J.; Dämianova, M. 1977: Hamster apigmented melanoma as a model for screening of potential antineoplastic drugs Neoplasma 24: 161-164
Brandberg, Y.; Sjödén, O.; Michelson, H. 1992: No symptoms of unnecessary anxiety or false confidence among participants of screening for malignant melanoma Lakartidningen 89(36): 2827
Shore, R.N.; Shore, P.; Monahan, N.M.; Sundeen, J. 2011: Serial screening for melanoma: measures and strategies that have consistently achieved early detection and cure Journal of Drugs in Dermatology: Jdd 10(3): 244-252
Spitz, J.L.; Silvers, D.N. 1995: Desmoplastic melanoma (or is it merely cicatrix?) arising at the site of biopsy within a conventional melanoma: pitfalls in the diagnosis desmoplastic melanoma Cutis 55(1): 40-44
Plauché, W.C.; Janney, F.A.; Curole, D.N. 1981: Screening for asymptomatic bacteriuria in pregnant patients: three office screening systems versus quantitative culture Southern Medical Journal 74(10): 1227-1229
Miura, T.; Ishikawa, S. 1970: Malignant melanoma--synopses from the seminar on malignant melanoma by International Group for the Clinical Study of Melanoma Gan no Rinsho. Japan Journal of Cancer Clinics 16(11): 1064-1070
Srinualnad, S.; Charoenkraikamol, C.; Toraksa, S.; Uiprasertkul, M.; Amornvesukit, T.; Taweemonkongsap, T.; Udompunturak, S.; Nualyong, C.; Tantiwong, A. 2006: Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day) Journal of the Medical Association of Thailand 89(1): 37-42